Literature DB >> 7310226

Elevated blood taurine levels in acute and evolving myocardial infarction.

J B Lombardini, M W Cooper.   

Abstract

Blood samples obtained from 97 consecutive patients admitted to the hospital for chest pain were analyzed for taurine concentrations. The mean value of the maximum taurine concentration in whole blood from AMI patients were greater than the mean value of the maximum taurine concentration in patients without AMI. There was no difference in plasma taurine levels between AMI and non-AMI patients, indicating that a cellular component(s) of whole blood was sequestering taurine. The increased blood taurine concentrations in the AMI patients evolved over the course of 70 hr and paralleled the increase in total CK levels. Blood taurine concentrations, in general, did not rise in patients who had chest pain of unknown etiology, skeletal muscle trauma, pleuritic pain, SVT/VT plus CV, acute pericarditis, acute cholecystitis, or angina pectoris. It is concluded that blood but not plasma taurine concentrations rise after acute myocardial injury and tend to be higher the more extensive the infarction. The mechanism of the blood taurine rise is unknown, but a myocardial source is probable. Also, there is evidence that the myocardium selectively leaks taurine, and not other amino acids. Monitoring blood taurine concentration in AMI may provide useful diagnostic and prognostic information.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7310226

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

1.  A loss of taurine and other amino acids from ventricles of patients undergoing bypass surgery.

Authors:  M S Suleiman; H C Fernando; W C Dihmis; J A Hutter; R A Chapman
Journal:  Br Heart J       Date:  1993-03

2.  Amino acid concentrations in blood of patients with an acute myocardial infarction.

Authors:  M W Cooper; J B Lombardini
Journal:  Experientia       Date:  1982-09-15

Review 3.  Perinatal taurine exposure affects adult arterial pressure control.

Authors:  Sanya Roysommuti; J Michael Wyss
Journal:  Amino Acids       Date:  2012-10-16       Impact factor: 3.520

4.  The importance of myocardial amino acids during ischemia and reperfusion in dilated left ventricle of patients with degenerative mitral valve disease.

Authors:  A Venturini; R Ascione; H Lin; E Polesel; G D Angelini; M-S Suleiman
Journal:  Mol Cell Biochem       Date:  2009-04-11       Impact factor: 3.396

5.  Effect of type of diet on blood and plasma taurine concentrations, cardiac biomarkers, and echocardiograms in 4 dog breeds.

Authors:  Darcy Adin; Lisa Freeman; Rebecca Stepien; John E Rush; Sonja Tjostheim; Heidi Kellihan; Michael Aherne; Michelle Vereb; Robert Goldberg
Journal:  J Vet Intern Med       Date:  2021-02-27       Impact factor: 3.333

6.  Cardiac taurine and principal amino acids in right and left ventricles of patients with either aortic valve stenosis or coronary artery disease: the importance of diabetes and gender.

Authors:  Martin Lewis; Ben Littlejohns; Hua Lin; Gianni D Angelini; M-Saadeh Suleiman
Journal:  Springerplus       Date:  2014-09-13

7.  Prospective study of dilated cardiomyopathy in dogs eating nontraditional or traditional diets and in dogs with subclinical cardiac abnormalities.

Authors:  Lisa Freeman; John Rush; Darcy Adin; Kelsey Weeks; Kristen Antoon; Sara Brethel; Suzanne Cunningham; Luis Dos Santos; Renee Girens; Robert Goldberg; Emily Karlin; Darleen Lessard; Katherine Lopez; Camden Rouben; Michelle Vereb; Vicky Yang
Journal:  J Vet Intern Med       Date:  2022-03-17       Impact factor: 3.333

8.  Association of Taurine with In-Hospital Mortality in Patients after Out-of-Hospital Cardiac Arrest: Results from the Prospective, Observational COMMUNICATE Study.

Authors:  Naemi Herzog; Rahel Laager; Emanuel Thommen; Madlaina Widmer; Alessia M Vincent; Annalena Keller; Christoph Becker; Katharina Beck; Sebastian Perrig; Luca Bernasconi; Peter Neyer; Stephan Marsch; Philipp Schuetz; Raoul Sutter; Kai Tisljar; Sabina Hunziker
Journal:  J Clin Med       Date:  2020-05-09       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.